Skip to main content
Tag

cancer clinical trials

Patient Navigation: 4 Ways to Gear Up for the Oncology Care Model
Patient Navigation: 4 Ways to Gear Up for the Oncology Care Model In The News

Patient Navigation: 4 Ways to Gear Up for the Oncology Care Model

Whether you are a participant in a value-based pilot like Oncology Care Model (OCM) or possibly a watchful bystander now is the time to integrate best practices for patient navigation to better serve your oncology patients and enhance care efficiency. A little background on the Oncology Care Model At its core, the Center for Medicare and Medicaid Innovation’s (CMMI) Oncology…
Carol Bush
December 3, 2015
IASLC 2015 16th World Conference Lung Cancer Poster Presentation Posters

IASLC 2015 16th World Conference Lung Cancer Poster Presentation

Improving Clinical Trial Knowledge and Referrals in NSCLC: Pilot Testing a Novel Healthcare IT Platform Joshua Bauml, MD1, Victoria Sherry, CRNP1, Jun J. Mao, MD, MSCE1, Jessica Rearden, PhD, RN2, Susan Qi Li, MS1, William Dudley, PhD3, Karen Hammelef, DNP, RN4, Carrie T. Stricker, PhD, RN4, Corey J. Langer, MD1 1Abramson Cancer Center at the University of Pennsylvania (Philadelphia, PA);…
Carevive
October 28, 2015
5 Key Takeaways From Cancer: The Emperor of All Maladies
5 Key Takeaways From Cancer: The Emperor of All Maladies In The News

5 Key Takeaways From Cancer: The Emperor of All Maladies

What has been labeled as the ultimate biography of cancer, Barak Goodman’s documentary Cancer: The Emperor of All Maladies, based on the book by Siddharta Mukherjee, aired in March and is causing quite the buzz within the oncology community. The amazing biopic covers a wide range of topics of cancer ranging from early treatments from 1900s, advancements in surgery, targeted…
Carevive
May 18, 2015
Multi-site Clinical Research Study Leverages Technology to Increase Clinical Trial Enrollment
New Carevive Care Planning System™ Functionality for Clinical Trial Accrual In The News

New Carevive Care Planning System™ Functionality for Clinical Trial Accrual

Lung cancer is one of the most common cancers in the United States, yet patients with advanced non-small cell lung cancer (NSCLC) have limited effective treatment options, often offering only modest improvements in survival. The landscape for NSCLC treatment is changing rapidly, however, and many new targeted and immunotherapy agents are being studied in NSCLC clinical trials. Low participation in…
Carevive
March 31, 2015